↓ Skip to main content

Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis

Overview of attention for article published in BMC Cancer, December 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis
Published in
BMC Cancer, December 2013
DOI 10.1186/1471-2407-13-564
Pubmed ID
Authors

Corrado Caracò, Nicola Mozzillo, Ugo Marone, Ester Simeone, Lucia Benedetto, Gianluca Di Monta, Maria Luisa Di Cecilia, Gerardo Botti, Paolo Antonio Ascierto

Abstract

Treatment of early and multiple cutaneous unresectable recurrences is a major therapeutic problem with around 80% of patients relapsing within 5 years. For lesions refractory to elective treatments, electrochemotherapy (ECT) involving electroporation combined with antineoplastic drug treatment appears to be a new potential option. This study was undertaken to analyze the short- and long-term responses of lesions treated with ECT with intravenous injection of bleomycin in melanoma patients with in-transit disease or distant cutaneous metastases.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 4%
Denmark 1 2%
Unknown 52 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 25%
Student > Ph. D. Student 11 20%
Student > Master 5 9%
Student > Doctoral Student 4 7%
Student > Bachelor 3 5%
Other 11 20%
Unknown 7 13%
Readers by discipline Count As %
Medicine and Dentistry 28 51%
Biochemistry, Genetics and Molecular Biology 8 15%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Unspecified 1 2%
Chemical Engineering 1 2%
Other 4 7%
Unknown 9 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2013.
All research outputs
#14,767,396
of 22,733,113 outputs
Outputs from BMC Cancer
#3,668
of 8,272 outputs
Outputs of similar age
#185,987
of 307,131 outputs
Outputs of similar age from BMC Cancer
#50
of 106 outputs
Altmetric has tracked 22,733,113 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,272 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,131 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 106 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.